User profiles for Donna S. Neuberg
 | Donna NeubergDana-Farber Cancer Institute Verified email at jimmy.harvard.edu Cited by 109213 |
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
…, A Norton, TA Lister, J Mesirov, DS Neuberg… - Nature medicine, 2002 - nature.com
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults,
is curable in less than 50% of patients. Prognostic models based on pre-treatment …
is curable in less than 50% of patients. Prognostic models based on pre-treatment …
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Diffuse large B cell lymphoma (DLBCL), the most common lymphoid malignancy in adults,
is a clinically and genetically heterogeneous disease that is further classified into …
is a clinically and genetically heterogeneous disease that is further classified into …
[HTML][HTML] Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
AA Ferrando, DS Neuberg, J Staunton, ML Loh… - Cancer cell, 2002 - cell.com
Human T cell leukemias can arise from oncogenes activated by specific chromosomal
translocations involving the T cell receptor genes. Here we show that five different T cell …
translocations involving the T cell receptor genes. Here we show that five different T cell …
[HTML][HTML] ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia
…, MJ Keating, JG Gribben, DS Neuberg… - … England Journal of …, 2004 - Mass Medical Soc
Background The course of chronic lymphocytic leukemia (CLL) is variable. In aggressive
disease, the CLL cells usually express an unmutated immunoglobulin heavy-chain variable-…
disease, the CLL cells usually express an unmutated immunoglobulin heavy-chain variable-…
Landscape of genomic alterations in cervical carcinomas
…, ML Cortes, H Greulich, CP Crum, DS Neuberg… - Nature, 2014 - nature.com
Cervical cancer is responsible for 10–15% of cancer-related deaths in women worldwide 1 ,
2 . The aetiological role of infection with high-risk human papilloma viruses (HPVs) in …
2 . The aetiological role of infection with high-risk human papilloma viruses (HPVs) in …
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal and treatment-refractory cancer.
Molecular stratification in pancreatic cancer remains rudimentary and does not yet inform …
Molecular stratification in pancreatic cancer remains rudimentary and does not yet inform …
[HTML][HTML] PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome
…, D de Jong, RT Hoppe, DS Neuberg… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Classical Hodgkin lymphomas (cHLs) include small numbers of malignant Reed-Sternberg
cells within an extensive but ineffective inflammatory/immune cell infiltrate. In cHL, …
cells within an extensive but ineffective inflammatory/immune cell infiltrate. In cHL, …
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia
…, M Schorin, VK Dalton, SE Lipshultz, DS Neuberg… - Blood, 2007 - ashpublications.org
The Dana-Farber Cancer Institute (DFCI) Childhood ALL Consortium Protocol 95-01 was
designed to minimize therapy-related morbidity for children with newly diagnosed ALL without …
designed to minimize therapy-related morbidity for children with newly diagnosed ALL without …
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup …
IW Flinn, DS Neuberg, MR Grever… - Journal of Clinical …, 2007 - ascopubs.org
Purpose The combination of fludarabine and cyclophosphamide is an effective regimen for
patients with chronic lymphocytic leukemia (CLL). However, it may be accompanied by …
patients with chronic lymphocytic leukemia (CLL). However, it may be accompanied by …
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective …
…, B Michon, MA Schorin, HJ Cohen, DS Neuberg… - The lancet …, 2010 - thelancet.com
Background Doxorubicin chemotherapy is associated with cardiomyopathy. Dexrazoxane
reduces cardiac damage during treatment with doxorubicin in children with acute …
reduces cardiac damage during treatment with doxorubicin in children with acute …